Keloid Scars. Hypertrophic scar
Conditions
Interventions
In each treatment session,the scar anesthetized with lidocaine gel then the keloids are removed by spot by spot method using plasma plexr device model plus.scars with a height of 2mm and less have bee
Sponsors
Islamic Azad University of Tehran Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 18 to 70 years old patients with keloid scars Volunteers who participated with informed consent Patients who have Possibility for repeated visits and follow-ups People with keloid scars with a maximum height of 5mm..
Exclusion criteria
Exclusion criteria: Patients who have history of previous treatments in the last six months Patients who have any chronic medical conditions that affects wound healing. People with underlying skin condition whose disease is exacerbated by skin irritations.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Keloid scar improvement. Timepoint: Before treatment and 5month after end of treatment. Method of measurement: Physical examination and scoring based on the Modified Vancouver Scar Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient's satisfaction. Timepoint: 5 months after end of treatment. Method of measurement: Answer the patient by choosing one of the option:1)not changed 2) good 3)very good 4)excellent.;Postinflammatory hyperpigmentation (PIH)as Side effects of treatment. Timepoint: 10 days, one month and 5 months after the intervention. Method of measurement: Physical examination.;Recurrence. Timepoint: 10 days, one month and 3 month and 5 months after the intervention. Method of measurement: Physical examination and scoring based on the Modified Vancouver Scar Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSepideh Tehrani
Islamic Azad University of Tehran Medical Sciences
Outcome results
None listed